Low ceruloplasmin levels define a distinct non-obese metabolic dysfunction-associated steatotic liver disease phenotype

Wain, Etienne;Gason, Rémi;André-Dumont, Stéphanie;Lanthier, Nicolas;Ausloos, Floriane;et.al.
(2026) EASL SLD Summit 2026 — Location: Budapest (26.February.2026)

Files

PosterEASLSLD26-Cérulo-MASLDstudy.pptx
  • Restricted Access
  • Microsoft Powerpoint XML
  • 1.48 MB
Request a copy

Details

Authors
Abstract
Low ceruloplasmin levels are classically linked to Wilson’s disease. Their significance in metabolic dysfunction–associated steatotic liver disease (MASLD), especially in intermediate ranges, remains unclear. We aimed to determine the prevalence and clinical relevance of low ceruloplasmin levels in a well-characterized cohort of MASLD patients.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Gason, R., André-Dumont, S., Lanthier, N., & et al. (2026). Low ceruloplasmin levels define a distinct non-obese metabolic dysfunction-associated steatotic liver disease phenotype. EASL SLD Summit 2026, Budapest. https://hdl.handle.net/2078.5/273814